THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Watch today!
Press Releases
- NextBio and Intel Collaborate to Optimize the Hadoop Stack and Advance Big Data Technologies in Genomics
- Alnylam Presents New Pre-clinical Data with its RNAi Therapeutic Program in Hemophilia
- Gen9 Announces Appointment of Kevin Munnelly as President and CEO
- The more gray matter you have, the more altruistic you are
- BioInvent: Announcement of topline results from the GLACIER study
- More Press Releases
Featured Jobs
-
Pharmacovigilance Scientist Job
Yoh - South San Francisco, CA, USA -
Hematology Oncology Consultant, Hematology - San Jose Job
Celgene Corporation - San Jose , CA, US -
Staff Scientist Job
Yoh - Wilmington, DE, USA -
Cell Culture Scientist Job
Yoh - Durham, NC, USA -
Development Scientist Job
Yoh - Brea, CA, USA
Latest Commentary